CLASS I Drug recall · Reported 10 Apr 2019 · FDA Enforcement Report
4% Sodium Bicarbonate Injection, USP 50 mEq (1 mEq/mL) recalled
Pfizer is recalling 4% Sodium Bicarbonate Injection, USP 50 mEq (1 mEq/mL) (84 mg/mL) Single-dose fliptop, distributed in Puerto Rico. The recall was initiated on 15 Mar 2019 and the FDA has classified it as Class I.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-1073-2019
- FDA event ID
- 82362
- Recalling firm
- Pfizer, New York, NY
- Classification
- Class I
- Status
- Terminated
- Recall initiated
- 15 Mar 2019
- FDA classified
- 29 Mar 2019
- Reported
- 10 Apr 2019
- Type
- Voluntary: Firm initiated
- Customers notified by
- Press Release
- Reason category
- Particulate Matter
- Drug class
- Injectable & IV Drugs
Timeline
| 15 Mar 2019 | Recall initiated by company | |
| 29 Mar 2019 | Classified by FDA | +14 days |
| 10 Apr 2019 | Published in enforcement report | +12 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Presence of Particulate Matter; glass particulates
Product as listed by the FDA
8.4% Sodium Bicarbonate Injection, USP 50 mEq (1 mEq/mL) 4.2 grams (84 mg/mL) 50 mL Single-dose fliptop vial, 25 vials per carton, Rx only Hospira, Inc. Lake Forest, IL 60045 USA ---- NDC 0409-6625-02
Where it was distributed
United States and Puerto Rico
Questions about this recall
Is 4% Sodium Bicarbonate Injection, USP 50 mEq (1 mEq/mL) (84 mg/mL) Single-dose fliptop recalled?
Yes. Pfizer recalled 4% Sodium Bicarbonate Injection, USP 50 mEq (1 mEq/mL) (84 mg/mL) Single-dose fliptop on 15 Mar 2019. The recall is Class I and its status is Terminated. Recall number D-1073-2019.
Why was it recalled?
Presence of Particulate Matter; glass particulates
Which lots are affected?
Lots: 79-238-EV Exp. 1 July 2019; 79-240-EV Exp. 1 July 2019; 80-088-EV Exp. 1 August 2019
Where was it sold?
United States and Puerto Rico
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class I mean?
Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.
Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from Pfizer
All 126| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Vial Label: 4% Sodium Bicarbonate Injection, USP, 50mEq/ (1 mEq/mL) recalledSodium Bicarbonate | PFIZER | Sterility | Nationwide |
| Drug | CLASS II | Vial Label: Epinephrine Injection, USP, 1mg/ 1 mg/mL) recalled by PFIZER | PFIZER | Sterility | Nationwide |
| Drug | CLASS II | Levoxyl (levothyroxine sodium tablets, USP), 50 mcg recalled by PfizerLevoxyl | Pfizer | Potency & Assay | NY |
| Drug | CLASS II | Bicillin L-A (penicillin G benzathine injectable recalled by PfizerBicillin L-a | Pfizer | Particulate Matter | Nationwide |
| Drug | CLASS II | Bicillin L-A (penicllin G benzathine injectable suspension) per-vial recalledBicillin L-a | Pfizer | Particulate Matter | Nationwide |